Results
2479
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,479 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ORCL | US$181.52 | 5.4% | 67.8% | US$502.9b | US$194.64 | PE43.7x | E15.7% | 0.9% | Software | ||
UNH | US$511.04 | -3.1% | -2.1% | US$460.8b | US$637.24 | PE32.6x | E18.8% | 1.6% | Healthcare | ||
JNJ | US$157.89 | 1.7% | -0.5% | US$373.2b | US$168.64 | PE27x | E8.4% | 3.1% | Pharmaceuticals & Biotech | ||
HSBA | UK£8.80 | 0.4% | 49.0% | UK£159.2b | UK£9.06 | PB1.1x | E2.0% | 5.9% | Banks | ||
AMD | US$114.69 | 2.7% | -30.2% | US$185.2b | US$148.34 | PE113.3x | E32.0% | n/a | Semiconductors | ||
PFE | US$25.89 | 1.6% | -6.4% | US$144.8b | US$31.18 | PE18.3x | E3.6% | 6.6% | Pharmaceuticals & Biotech | ||
LOW | US$246.68 | -1.4% | 8.3% | US$141.6b | US$282.36 | PE20.4x | E5.8% | 1.9% | Retail | ||
COP | US$99.57 | 1.2% | -11.8% | US$124.0b | US$129.83 | PE13.7x | E4.5% | 3.1% | Energy | ||
TD | CA$85.56 | -0.01% | 6.5% | CA$149.0b | CA$89.33 | PB1.3x | E11.5% | 4.9% | Banks | ||
IBKR | US$232.65 | 1.1% | 121.4% | US$99.5b | US$225.80 | PE33.6x | E2.6% | 0.4% | Diversified Financials | ||
INVE A | SEK 320.00 | 0.1% | 25.4% | SEK 980.9b | SEK 315.00 | PE8.6x | E-48.3% | 1.6% | Diversified Financials | ||
BP. | UK£4.52 | -2.6% | -3.5% | UK£72.5b | UK£4.88 | PE241.1x | E34.5% | 5.6% | Energy | ||
ATCO A | SEK 187.40 | -1.0% | 4.3% | SEK 863.7b | SEK 187.05 | PE30.6x | E6.9% | 1.6% | Capital Goods | ||
TRI | CA$245.45 | -2.3% | 15.8% | CA$110.9b | CA$253.24 | PE35.5x | E-1.4% | 1.4% | Commercial Services | ||
ITW | US$264.10 | 3.1% | 2.3% | US$77.0b | US$263.73 | PE22.2x | E1.9% | 2.3% | Capital Goods | ||
1299 | HK$55.05 | 1.0% | -15.8% | HK$587.0b | HK$92.77 | PE15.6x | E13.9% | 3.0% | Insurance | ||
CRH | US$106.10 | 1.8% | 36.6% | US$74.8b | US$114.28 | PE20.8x | E9.5% | 1.3% | Materials | ||
GSK | UK£14.47 | 0.2% | -13.3% | UK£58.7b | UK£17.97 | PE22.9x | E16.9% | 4.2% | Pharmaceuticals & Biotech | ||
SPG | US$185.93 | 1.1% | 23.7% | US$70.1b | US$190.56 | PB20.9x | E-0.5% | 4.5% | Real Estate | ||
NAB | AU$35.11 | -14.9% | 4.9% | AU$107.5b | AU$34.03 | PB1.7x | E2.1% | 4.8% | Banks | ||
WBC | AU$31.22 | -9.9% | 20.7% | AU$107.0b | AU$29.59 | PB1.5x | E-0.1% | 4.9% | Banks | ||
FDX | US$266.87 | 1.6% | 10.5% | US$64.4b | US$320.69 | PE16.6x | E12.8% | 2.1% | Transportation | ||
CNR | CA$145.73 | -0.6% | -16.4% | CA$91.4b | CA$167.71 | PE20.6x | E7.9% | 2.3% | Transportation | ||
VOLV B | SEK 329.70 | 1.3% | 18.5% | SEK 668.2b | SEK 327.05 | PE13.3x | E4.3% | 5.6% | Capital Goods |